Cargando…
Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
OBJECTIVE: To define which oxidative stress markers could be used as diagnostic tools in the assessment of post-infarction heart failure (HF). METHODS: This observational study enrolled patients with HF that were divided into three subgroups (ejection fraction [EF] ≥ 50%; EF 40–49%; EF < 40%) and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793051/ https://www.ncbi.nlm.nih.gov/pubmed/36564997 http://dx.doi.org/10.1177/03000605221139711 |
_version_ | 1784859771492368384 |
---|---|
author | Cvetkovic, Tatjana Saric, Sandra Stefanovic, Nikola Stojiljkovic, Vladana Djordjevic, Branka Stojanovic, Dijana Cvetkovic, Mina Deljanin Ilic, Marina |
author_facet | Cvetkovic, Tatjana Saric, Sandra Stefanovic, Nikola Stojiljkovic, Vladana Djordjevic, Branka Stojanovic, Dijana Cvetkovic, Mina Deljanin Ilic, Marina |
author_sort | Cvetkovic, Tatjana |
collection | PubMed |
description | OBJECTIVE: To define which oxidative stress markers could be used as diagnostic tools in the assessment of post-infarction heart failure (HF). METHODS: This observational study enrolled patients with HF that were divided into three subgroups (ejection fraction [EF] ≥ 50%; EF 40–49%; EF < 40%) and age- and sex-matched healthy control subjects. The plasma concentrations of advanced oxidation protein products (AOPP), thiobarbituric acid reactive substances, catalase activity and free thiols were determined in all participants. RESULTS: The study enrolled 81 patients with HF and 68 healthy control subjects. There were significant differences in the values of oxidative stress markers between patients and controls. Oxidative stress parameters did not differ between the subgroups of patients, except for AOPP, which was significantly higher in the EF < 40% group. Univariate and multivariate logistic regression analyses showed an association between AOPP and HF in the EF ≥ 50% group, while receiver operating characteristic (ROC) curve analysis identified a cut-off value of 60.89 µmol/l for AOPP. CONCLUSIONS: Based on the ROC curve analysis of AOPP and the higher significance in the multivariate analyses for patients with EF ≥ 50%, these current results suggest that AOPP could be a useful additional tool in the assessment of post-infarction HF. |
format | Online Article Text |
id | pubmed-9793051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-97930512022-12-28 Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure Cvetkovic, Tatjana Saric, Sandra Stefanovic, Nikola Stojiljkovic, Vladana Djordjevic, Branka Stojanovic, Dijana Cvetkovic, Mina Deljanin Ilic, Marina J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To define which oxidative stress markers could be used as diagnostic tools in the assessment of post-infarction heart failure (HF). METHODS: This observational study enrolled patients with HF that were divided into three subgroups (ejection fraction [EF] ≥ 50%; EF 40–49%; EF < 40%) and age- and sex-matched healthy control subjects. The plasma concentrations of advanced oxidation protein products (AOPP), thiobarbituric acid reactive substances, catalase activity and free thiols were determined in all participants. RESULTS: The study enrolled 81 patients with HF and 68 healthy control subjects. There were significant differences in the values of oxidative stress markers between patients and controls. Oxidative stress parameters did not differ between the subgroups of patients, except for AOPP, which was significantly higher in the EF < 40% group. Univariate and multivariate logistic regression analyses showed an association between AOPP and HF in the EF ≥ 50% group, while receiver operating characteristic (ROC) curve analysis identified a cut-off value of 60.89 µmol/l for AOPP. CONCLUSIONS: Based on the ROC curve analysis of AOPP and the higher significance in the multivariate analyses for patients with EF ≥ 50%, these current results suggest that AOPP could be a useful additional tool in the assessment of post-infarction HF. SAGE Publications 2022-12-23 /pmc/articles/PMC9793051/ /pubmed/36564997 http://dx.doi.org/10.1177/03000605221139711 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Retrospective Clinical Research Report Cvetkovic, Tatjana Saric, Sandra Stefanovic, Nikola Stojiljkovic, Vladana Djordjevic, Branka Stojanovic, Dijana Cvetkovic, Mina Deljanin Ilic, Marina Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure |
title | Plasma advanced oxidation products as an additional tool in
assessment of post-infarction heart failure |
title_full | Plasma advanced oxidation products as an additional tool in
assessment of post-infarction heart failure |
title_fullStr | Plasma advanced oxidation products as an additional tool in
assessment of post-infarction heart failure |
title_full_unstemmed | Plasma advanced oxidation products as an additional tool in
assessment of post-infarction heart failure |
title_short | Plasma advanced oxidation products as an additional tool in
assessment of post-infarction heart failure |
title_sort | plasma advanced oxidation products as an additional tool in
assessment of post-infarction heart failure |
topic | Retrospective Clinical Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793051/ https://www.ncbi.nlm.nih.gov/pubmed/36564997 http://dx.doi.org/10.1177/03000605221139711 |
work_keys_str_mv | AT cvetkovictatjana plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure AT saricsandra plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure AT stefanovicnikola plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure AT stojiljkovicvladana plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure AT djordjevicbranka plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure AT stojanovicdijana plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure AT cvetkovicmina plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure AT deljaninilicmarina plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure |